CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: quinoxaline
Accession: CHEBI:36616
browse the term
Definition: A naphthyridine in which the nitrogens are at positions 1 and 4.
Synonyms: related_synonym: 1,4-benzodiazine; 1,4-diazanaphthalene; 1,4-naphthyridine; Chinoxalin; Formula=C8H6N2; InChI=1S/C8H6N2/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6H; InChIKey=XSCHRSMBECNVNS-UHFFFAOYSA-N; SMILES=c1ccc2nccnc2c1; benzo[a]pyrazine; benzoparadiazine; benzopyrazine
xref: Beilstein:109351; CAS:91-19-0; Gmelin:82755; KEGG:C18575; PMID:16406213; PMID:24328679; PMID:24476762; PMID:27349448; Reaxys:109351; Wikipedia:Quinoxaline
G
Bax
BCL2-associated X protein
decreases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased expression of BAX mRNA
CTD
PMID:23810796
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of BCL2 mRNA; 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of BCL2 protein
CTD
PMID:23810796
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CDKN1A mRNA; 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CDKN1A protein
CTD
PMID:23810796
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
affects activity increases expression
ISO
CYP1A1 affects the activity of 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CYP1A1 mRNA
CTD
PMID:2334931 PMID:23810796
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases activity multiple interactions increases expression
ISO
CYP1A2 results in increased activity of 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine CYP1A2 protein results in increased metabolism of and results in increased susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of CYP1A2 mRNA
CTD
PMID:2334931 PMID:23810796 PMID:28160022
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Eps8l3
EPS8-like 3
affects response to substance
ISO
EPS8L3 protein affects the susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine
CTD
PMID:19223546
NCBI chr 3:107,781,177...107,800,216
Ensembl chr 3:107,784,545...107,800,216
G
Gadd45a
growth arrest and DNA-damage-inducible 45 alpha
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of GADD45A mRNA
CTD
PMID:23810796
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
G
H2ax
H2A.X variant histone
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of H2AX protein modified form
CTD
PMID:28160022
NCBI chr 9:44,246,012...44,247,374
Ensembl chr 9:44,245,991...44,247,374
G
Mdm2
transformed mouse 3T3 cell double minute 2
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of MDM2 mRNA
CTD
PMID:23810796
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Nat2
N-acetyltransferase 2 (arylamine N-acetyltransferase)
multiple interactions
ISO
NAT2 protein results in increased metabolism of and results in increased susceptibility to 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine
CTD
PMID:28160022
NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236
G
Slc22a1
solute carrier family 22 (organic cation transporter), member 1
multiple interactions decreases activity
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine inhibits the reaction [SLC22A1 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide] 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased activity of SLC22A1 protein
CTD
PMID:30189235
NCBI chr17:12,867,761...12,894,725
Ensembl chr17:12,867,756...12,894,716
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
decreases activity multiple interactions
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased activity of SLC22A2 protein 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine inhibits the reaction [SLC22A2 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
CTD
PMID:30189235
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Slc22a3
solute carrier family 22 (organic cation transporter), member 3
decreases activity multiple interactions
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased activity of SLC22A3 protein 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine inhibits the reaction [SLC22A3 protein results in increased import of 4-(4-(dimethylamino)styryl)-1-methylpyridinium iodide]
CTD
PMID:30189235
NCBI chr17:12,638,859...12,726,591
Ensembl chr17:12,637,847...12,726,591
G
Trp53
transformation related protein 53
decreases expression increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in decreased expression of TP53 mRNA 3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of TP53 protein
CTD
PMID:23810796
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
increases expression
ISO
3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of UGT1A1 mRNA
CTD
PMID:23810796
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Akt1
thymoma viral proto-oncogene 1
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]
CTD
PMID:25896968
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]
CTD
PMID:25896968
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]
CTD
PMID:25896968
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Pdgfb
platelet derived growth factor, B polypeptide
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFB mRNA]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased secretion of PDGFB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of AKT1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK1 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of MAPK3 protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline results in decreased susceptibility to [PDGFB protein binds to PDGFB protein]
CTD
PMID:16149045 PMID:23457620 PMID:25896968
NCBI chr15:79,880,066...79,899,178
Ensembl chr15:79,880,075...79,899,178
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
multiple interactions
ISO
6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [Nicotine results in increased expression of PDGFRB protein]; 6,7-dimethoxy-2-phenylquinoxaline inhibits the reaction [PDGFB protein results in increased phosphorylation of PDGFRB protein]
CTD
PMID:16149045 PMID:25896968
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Aco2
aconitase 2, mitochondrial
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Kainic Acid results in decreased activity of ACO2 protein]
CTD
PMID:11520895
NCBI chr15:81,756,664...81,799,338
Ensembl chr15:81,756,510...81,799,334
G
Bdnf
brain derived neurotrophic factor
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Pilocarpine results in increased expression of BDNF mRNA alternative form]
CTD
PMID:15183516
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Casp3
caspase 3
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid inhibits the reaction [Phencyclidine results in increased activity of CASP3 protein]]
CTD
PMID:24995437
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Fos
FBJ osteosarcoma oncogene
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased expression of FOS]
CTD
PMID:10401552
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Gfap
glial fibrillary acidic protein
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of GFAP protein]
CTD
PMID:21863293
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
G
Gria1
glutamate receptor, ionotropic, AMPA1 (alpha 1)
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA1 protein
CTD
PMID:19674091
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
G
Gria2
glutamate receptor, ionotropic, AMPA2 (alpha 2)
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione results in increased expression of and results in increased localization of GRIA2 protein
CTD
PMID:19674091
NCBI chr 3:80,588,757...80,711,534
Ensembl chr 3:80,588,757...80,710,142
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions
EXP ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK1 protein] 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK1 protein]
CTD
PMID:15385614 PMID:19850060
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions
EXP ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Homocysteine results in increased phosphorylation of MAPK3 protein] 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Capsaicin results in increased phosphorylation of MAPK3 protein]
CTD
PMID:15385614 PMID:19850060
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Nefl
neurofilament, light polypeptide
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFL protein]; 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [N-Methylaspartate results in decreased expression of NEFL mRNA]; 6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [Rotenone results in decreased expression of NEFL mRNA]
CTD
PMID:21863293 PMID:31969611
NCBI chr14:68,321,312...68,326,544
Ensembl chr14:68,321,312...68,326,544
G
Nefm
neurofilament, medium polypeptide
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of NEFM protein]
CTD
PMID:21863293
NCBI chr14:68,356,994...68,362,453
Ensembl chr14:68,320,039...68,362,295
G
Sct
secretin
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [SCT protein results in increased secretion of gamma-Aminobutyric Acid]
CTD
PMID:15963647
NCBI chr 7:140,858,243...140,859,082
Ensembl chr 7:140,858,243...140,859,046
G
Tac1
tachykinin 1
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [L 703606 results in increased activity of TAC1 protein]
CTD
PMID:14985054
NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
G
Vim
vimentin
multiple interactions
ISO
6-Cyano-7-nitroquinoxaline-2,3-dione inhibits the reaction [diphenylditelluride results in decreased phosphorylation of VIM protein]
CTD
PMID:21863293
NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637
G
Adra2a
adrenergic receptor, alpha 2a
multiple interactions
ISO EXP
Brimonidine Tartrate inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein]; Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]; Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]; Prazosin inhibits the reaction [Phenylephrine promotes the reaction [Brimonidine Tartrate binds to and results in increased activity of ADRA2A protein]]; Yohimbine inhibits the reaction [Brimonidine Tartrate promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]]
CTD
PMID:8397342 PMID:10742289 PMID:12208771 PMID:12598592
NCBI chr19:54,033,690...54,037,413
Ensembl chr19:54,032,582...54,037,413
G
Agt
angiotensinogen
multiple interactions
ISO
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased abundance of Superoxides]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]
CTD
PMID:18250367
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Cftr
cystic fibrosis transmembrane conductance regulator
multiple interactions
EXP
Brimonidine Tartrate inhibits the reaction [CFTR protein affects the transport of Chlorides]
CTD
PMID:12598592
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Creb1
cAMP responsive element binding protein 1
increases phosphorylation
ISO
Brimonidine Tartrate results in increased phosphorylation of CREB1 protein
CTD
PMID:17680988
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Prkca
protein kinase C, alpha
affects localization multiple interactions
ISO
Brimonidine Tartrate affects the localization of PRKCA protein Nitric Oxide deficiency promotes the reaction [Brimonidine Tartrate affects the localization of PRKCA protein]
CTD
PMID:12388232
NCBI chr11:107,824,213...108,237,360
Ensembl chr11:107,824,213...108,234,754
G
Prkcd
protein kinase C, delta
affects localization multiple interactions
ISO
Brimonidine Tartrate affects the localization of PRKCD protein Nitric Oxide deficiency inhibits the reaction [Brimonidine Tartrate affects the localization of PRKCD protein]
CTD
PMID:12388232
NCBI chr14:30,317,310...30,348,637
Ensembl chr14:30,317,311...30,348,167
G
Rhoa
ras homolog family member A
multiple interactions
ISO
1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; 4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; bisindolylmaleimide I inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; Brimonidine Tartrate promotes the reaction [AGT protein results in increased activity of RHOA protein]; diphenyleneiodonium inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]; tempol inhibits the reaction [Brimonidine Tartrate promotes the reaction [AGT protein results in increased expression of RHOA protein]]
CTD
PMID:18250367
NCBI chr 9:108,183,359...108,215,142
Ensembl chr 9:108,183,328...108,215,133
G
Slc22a2
solute carrier family 22 (organic cation transporter), member 2
multiple interactions
ISO
Brimonidine Tartrate inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr17:12,803,076...12,847,376
Ensembl chr17:12,803,019...12,847,375
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
increases expression
ISO
Carbadox results in increased expression of CDKN1A mRNA; Carbadox results in increased expression of CDKN1A protein
CTD
PMID:26558467
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Mdm2
transformed mouse 3T3 cell double minute 2
increases expression
ISO
Carbadox results in increased expression of MDM2 mRNA
CTD
PMID:26558467
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Mki67
antigen identified by monoclonal antibody Ki 67
decreases expression
ISO
Carbadox results in decreased expression of MKI67 protein
CTD
PMID:26558467
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Top2a
topoisomerase (DNA) II alpha
decreases expression
ISO
Carbadox results in decreased expression of TOP2A protein
CTD
PMID:26558467
NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015
G
Car9
carbonic anhydrase 9
multiple interactions
ISO
CAY10591 inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein]
CTD
PMID:34520103
NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729
G
Sirt1
sirtuin 1
increases activity
ISO
CAY10591 results in increased activity of SIRT1 protein
CTD
PMID:34520103
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Adra1b
adrenergic receptor, alpha 1b
multiple interactions
ISO
cyclazosin binds to and results in decreased activity of ADRA1B protein
CTD
PMID:15951348
NCBI chr11:43,665,432...43,792,076
Ensembl chr11:43,665,433...43,792,037
G
Ache
acetylcholinesterase
multiple interactions decreases activity
ISO
Arsenic promotes the reaction [quinalphos results in decreased activity of ACHE protein]; quinalphos promotes the reaction [Arsenic results in decreased activity of ACHE protein] quinalphos metabolite results in decreased activity of ACHE protein; quinalphos results in decreased activity of ACHE protein
CTD
PMID:32270456 PMID:33844597
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Ahr
aryl-hydrocarbon receptor
multiple interactions
EXP
quinalphos binds to and results in increased activity of AHR protein
CTD
PMID:18835618
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Alb
albumin
multiple interactions
ISO
[Arsenic co-treated with quinalphos] results in decreased expression of ALB protein
CTD
PMID:32270456
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Ar
androgen receptor
multiple interactions
ISO
Dihydrotestosterone inhibits the reaction [quinalphos results in increased activity of AR protein]
CTD
PMID:15064155
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Bche
butyrylcholinesterase
decreases activity multiple interactions
ISO
quinalphos results in decreased activity of BCHE protein pralidoxime inhibits the reaction [quinalphos results in decreased activity of BCHE protein]
CTD
PMID:24052565
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Cat
catalase
multiple interactions decreases activity
EXP ISO
Plant Extracts inhibits the reaction [quinalphos results in decreased activity of CAT protein] [Arsenic co-treated with quinalphos] results in decreased activity of CAT protein
CTD
PMID:24581381 PMID:32270456
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
increases expression
EXP
quinalphos results in increased expression of CYP19A1 mRNA
CTD
PMID:34014595
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
G
Cyp26b1
cytochrome P450, family 26, subfamily b, polypeptide 1
decreases expression multiple interactions
EXP
quinalphos results in decreased expression of CYP26B1 mRNA Plant Extracts inhibits the reaction [quinalphos results in decreased expression of CYP26B1 mRNA]
CTD
PMID:24581381
NCBI chr 6:84,548,396...84,570,890
Ensembl chr 6:84,548,396...84,570,890
G
Esr1
estrogen receptor 1 (alpha)
increases activity
ISO
quinalphos results in increased activity of ESR1 protein
CTD
PMID:15064155
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
increases activity
ISO
quinalphos results in increased activity of ESR2 protein
CTD
PMID:15064155
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
multiple interactions affects activity
ISO
[Monocrotophos co-treated with quinalphos] affects the activity of G6PD protein quinalphos affects the activity of G6PD protein
CTD
PMID:24248738
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gsr
glutathione reductase
multiple interactions decreases activity affects activity
ISO
[Arsenic co-treated with quinalphos] results in decreased activity of GSR protein; [Monocrotophos co-treated with quinalphos] affects the activity of GSR protein quinalphos results in decreased activity of GSR protein quinalphos affects the activity of GSR protein
CTD
PMID:24248738 PMID:32270456
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Hsd3b3
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 3
decreases expression multiple interactions
EXP
quinalphos results in decreased expression of HSD3B3 mRNA Plant Extracts inhibits the reaction [quinalphos results in decreased expression of HSD3B3 mRNA]
CTD
PMID:24581381
NCBI chr 3:98,648,792...98,672,465
Ensembl chr 3:98,648,839...98,670,443
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO EXP
quinalphos binds to and results in increased activity of NR1I2 protein
CTD
PMID:21115097
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Star
steroidogenic acute regulatory protein
multiple interactions decreases expression
EXP
Plant Extracts inhibits the reaction [quinalphos results in decreased expression of STAR mRNA]; Plant Extracts inhibits the reaction [quinalphos results in decreased expression of STAR protein] quinalphos results in decreased expression of STAR mRNA; quinalphos results in decreased expression of STAR protein
CTD
PMID:24581381
NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
G
Trp53
transformation related protein 53
affects activity
ISO
quinalphos metabolite affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Akr1c20
aldo-keto reductase family 1, member C20
affects expression increases expression
ISO
quinomethionate affects the expression of AKR1C1 mRNA quinomethionate results in increased expression of AKR1C1 mRNA
CTD
PMID:15387888 PMID:18214805
NCBI chr13:4,536,855...4,573,353
Ensembl chr13:4,536,848...4,573,344
G
Btg2
BTG anti-proliferation factor 2
affects expression
ISO
quinomethionate affects the expression of BTG2 mRNA
CTD
PMID:15387888
NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858
G
Cebpd
CCAAT/enhancer binding protein delta
affects expression
ISO
quinomethionate affects the expression of CEBPD mRNA
CTD
PMID:15387888
NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895
G
Cxcl2
C-X-C motif chemokine ligand 2
affects expression
ISO
quinomethionate affects the expression of CXCL2 mRNA
CTD
PMID:15387888
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Etv4
ets variant 4
affects expression
ISO
quinomethionate affects the expression of ETV4 mRNA
CTD
PMID:15387888
NCBI chr11:101,660,573...101,677,963
Ensembl chr11:101,660,568...101,676,197
G
Ewsr1
Ewing sarcoma breakpoint region 1
affects expression
ISO
quinomethionate affects the expression of EWSR1 mRNA
CTD
PMID:15387888
NCBI chr11:5,019,687...5,049,314
Ensembl chr11:5,019,689...5,049,266
G
Fkbp5
FK506 binding protein 5
affects expression
ISO
quinomethionate affects the expression of FKBP5 mRNA
CTD
PMID:15387888
NCBI chr17:28,617,727...28,705,123
Ensembl chr17:28,618,068...28,736,501
G
Fos
FBJ osteosarcoma oncogene
affects expression
ISO
quinomethionate affects the expression of FOS mRNA
CTD
PMID:15387888
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Gadd45a
growth arrest and DNA-damage-inducible 45 alpha
affects expression
ISO
quinomethionate affects the expression of GADD45A mRNA
CTD
PMID:15387888
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
G
Hnrnpf
heterogeneous nuclear ribonucleoprotein F
affects expression
ISO
quinomethionate affects the expression of HNRNPF mRNA
CTD
PMID:15387888
NCBI chr 6:117,877,301...117,902,583
Ensembl chr 6:117,877,285...117,902,583
G
Junb
jun B proto-oncogene
affects expression
ISO
quinomethionate affects the expression of JUNB mRNA
CTD
PMID:15387888
NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347
G
Jund
jun D proto-oncogene
affects expression
ISO
quinomethionate affects the expression of JUND mRNA
CTD
PMID:15387888
NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
G
Lmnb1
lamin B1
affects expression
ISO
quinomethionate affects the expression of LMNB1 mRNA
CTD
PMID:15387888
NCBI chr18:56,840,885...56,886,496
Ensembl chr18:56,840,885...56,886,496
G
Map2k1
mitogen-activated protein kinase kinase 1
affects expression
ISO
quinomethionate affects the expression of MAP2K1 mRNA
CTD
PMID:15387888
NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913
G
Mat2a
methionine adenosyltransferase 2A
affects expression
ISO
quinomethionate affects the expression of MAT2A mRNA
CTD
PMID:15387888
NCBI chr 6:72,409,779...72,416,539
Ensembl chr 6:72,409,782...72,416,541
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
affects expression
ISO
quinomethionate affects the expression of NFKBIA mRNA
CTD
PMID:15387888
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Phb1
prohibitin 1
affects expression
ISO
quinomethionate affects the expression of PHB1 mRNA
CTD
PMID:15387888
NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599
G
Ppib
peptidylprolyl isomerase B
affects expression
ISO
quinomethionate affects the expression of PPIB mRNA
CTD
PMID:15387888
NCBI chr 9:65,967,451...65,973,911
Ensembl chr 9:65,967,504...65,973,905
G
Raf1
v-raf-leukemia viral oncogene 1
affects expression
ISO
quinomethionate affects the expression of RAF1 mRNA
CTD
PMID:15387888
NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
G
Rarg
retinoic acid receptor, gamma
affects expression
ISO
quinomethionate affects the expression of RARG mRNA
CTD
PMID:15387888
NCBI chr15:102,143,373...102,165,891
Ensembl chr15:102,143,373...102,165,952
G
Rbm39
RNA binding motif protein 39
affects expression
ISO
quinomethionate affects the expression of RBM39 mRNA
CTD
PMID:15387888
NCBI chr 2:155,989,159...156,022,649
Ensembl chr 2:155,989,159...156,022,158
G
Rnd3
Rho family GTPase 3
affects expression
ISO
quinomethionate affects the expression of RND3 mRNA
CTD
PMID:15387888
NCBI chr 2:51,020,451...51,039,123
Ensembl chr 2:51,020,450...51,039,123
G
Sumo1
small ubiquitin-like modifier 1
affects expression
ISO
quinomethionate affects the expression of SUMO1 mRNA
CTD
PMID:15387888
NCBI chr 1:59,678,593...59,709,993
Ensembl chr 1:59,625,717...59,709,993
G
Tgfa
transforming growth factor alpha
affects expression
ISO
quinomethionate affects the expression of TGFA mRNA
CTD
PMID:15387888
NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701
G
Uqcrc2
ubiquinol cytochrome c reductase core protein 2
affects expression
ISO
quinomethionate affects the expression of UQCRC2 mRNA
CTD
PMID:15387888
NCBI chr 7:120,234,412...120,258,746
Ensembl chr 7:120,234,399...120,258,747
G
Vegfa
vascular endothelial growth factor A
affects expression
ISO
quinomethionate affects the expression of VEGFA mRNA
CTD
PMID:15387888
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Acox1
acyl-Coenzyme A oxidase 1, palmitoyl
increases activity multiple interactions increases expression
ISO
quizalofop-ethyl analog results in increased activity of ACOX1 protein PPARA protein affects the reaction [quizalofop-ethyl analog results in increased activity of ACOX1 protein]; PPARA protein affects the reaction [quizalofop-ethyl analog results in increased expression of ACOX1 mRNA]
CTD
PMID:29626562
NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871
G
Cat
catalase
increases activity
ISO
quizalofop-ethyl analog results in increased activity of CAT protein
CTD
PMID:29626562
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ppara
peroxisome proliferator activated receptor alpha
increases response to substance multiple interactions
ISO
PPARA protein results in increased susceptibility to quizalofop-ethyl analog PPARA protein affects the reaction [quizalofop-ethyl analog results in increased activity of ACOX1 protein]; PPARA protein affects the reaction [quizalofop-ethyl analog results in increased expression of ACOX1 mRNA]
CTD
PMID:29626562
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Pparg
peroxisome proliferator activated receptor gamma
increases activity
ISO
quizalofop-ethyl results in increased activity of PPARG protein
CTD
PMID:31086981
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
A2m
alpha-2-macroglobulin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of A2M mRNA
CTD
PMID:27935865
NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186
G
Abca8b
ATP-binding cassette, sub-family A member 8b
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ABCA8B mRNA
CTD
PMID:27935865
NCBI chr11:109,823,016...109,886,642
Ensembl chr11:109,823,016...109,886,671
G
Abhd14b
abhydrolase domain containing 14b
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ABHD14B mRNA]
CTD
PMID:29891994
NCBI chr 9:106,324,936...106,330,122
Ensembl chr 9:106,324,658...106,330,122
G
Acod1
aconitate decarboxylase 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ACOD1 mRNA
CTD
PMID:27935865
NCBI chr14:103,284,448...103,294,009
Ensembl chr14:103,284,413...103,294,009
G
Acta2
actin alpha 2, smooth muscle, aorta
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ACTA2 mRNA]
CTD
PMID:29891994
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
G
Actg2
actin, gamma 2, smooth muscle, enteric
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ACTG2 mRNA
CTD
PMID:27935865
NCBI chr 6:83,489,891...83,513,233
Ensembl chr 6:83,489,887...83,513,247
G
Adam8
a disintegrin and metallopeptidase domain 8
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADAM8 mRNA
CTD
PMID:27935865
NCBI chr 7:139,558,845...139,573,016
Ensembl chr 7:139,558,845...139,572,475
G
Adcy5
adenylate cyclase 5
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCY5 mRNA
CTD
PMID:27935865
NCBI chr16:34,974,933...35,126,108
Ensembl chr16:34,975,247...35,126,108
G
Adcyap1r1
adenylate cyclase activating polypeptide 1 receptor 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCYAP1R1 mRNA
CTD
PMID:27935865
NCBI chr 6:55,428,486...55,478,440
Ensembl chr 6:55,428,963...55,478,436
G
Adgra2
adhesion G protein-coupled receptor A2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADGRA2 mRNA
CTD
PMID:27935865
NCBI chr 8:27,575,546...27,613,464
Ensembl chr 8:27,575,611...27,613,464
G
Adgrg3
adhesion G protein-coupled receptor G3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ADGRG3 mRNA
CTD
PMID:27935865
NCBI chr 8:95,743,742...95,771,878
Ensembl chr 8:95,744,320...95,771,878
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADIPOQ mRNA
CTD
PMID:27935865
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adora1
adenosine A1 receptor
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADORA1 mRNA
CTD
PMID:27935865
NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169
G
Agbl1
ATP/GTP binding protein-like 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AGBL1 mRNA
CTD
PMID:27935865
NCBI chr 7:75,879,311...76,774,446
Ensembl chr 7:75,879,635...76,774,446
G
Agtr2
angiotensin II receptor, type 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AGTR2 mRNA
CTD
PMID:27935865
NCBI chr X:21,350,863...21,355,072
Ensembl chr X:21,350,783...21,355,403
G
Akr1d1
aldo-keto reductase family 1, member D1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of AKR1D1 mRNA
CTD
PMID:27935865
NCBI chr 6:37,506,913...37,551,856
Ensembl chr 6:37,507,108...37,545,750
G
Ambp
alpha 1 microglobulin/bikunin precursor
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of AMBP mRNA
CTD
PMID:27935865
NCBI chr 4:63,061,512...63,072,409
Ensembl chr 4:63,061,512...63,073,036
G
Aoc3
amine oxidase, copper containing 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AOC3 mRNA
CTD
PMID:27935865
NCBI chr11:101,221,432...101,230,256
Ensembl chr11:101,221,431...101,232,764
G
Apoc2
apolipoprotein C2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of APOC2 mRNA
CTD
PMID:27935865
NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866
G
Apol6
apolipoprotein L 6
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of APOL6 mRNA
CTD
PMID:27935865
NCBI chr15:76,929,195...76,941,308
Ensembl chr15:76,928,929...76,941,306
G
Arhgap36
Rho GTPase activating protein 36
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ARHGAP36 mRNA
CTD
PMID:27935865
NCBI chr X:48,537,237...48,589,121
Ensembl chr X:48,552,822...48,589,121
G
Arhgef19
Rho guanine nucleotide exchange factor 19
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARHGEF19 mRNA]
CTD
PMID:29891994
NCBI chr 4:140,966,916...140,985,226
Ensembl chr 4:140,966,810...140,984,875
G
Armcx6
armadillo repeat containing, X-linked 6
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ARMCX6 mRNA]
CTD
PMID:29891994
NCBI chr X:133,649,204...133,657,236
Ensembl chr X:133,649,210...133,652,166
G
Asb10
ankyrin repeat and SOCS box-containing 10
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ASB10 mRNA
CTD
PMID:27935865
NCBI chr 5:24,737,695...24,745,976
Ensembl chr 5:24,737,695...24,745,976
G
Asb13
ankyrin repeat and SOCS box-containing 13
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ASB13 mRNA]
CTD
PMID:29891994
NCBI chr13:3,683,589...3,703,822
Ensembl chr13:3,684,032...3,703,822
G
Asb16
ankyrin repeat and SOCS box-containing 16
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ASB16 mRNA
CTD
PMID:27935865
NCBI chr11:102,159,577...102,170,280
Ensembl chr11:102,159,569...102,170,288
G
Ascl2
achaete-scute family bHLH transcription factor 2
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ASCL2 mRNA]
CTD
PMID:29891994
NCBI chr 7:142,520,559...142,523,001
Ensembl chr 7:142,520,566...142,523,001
G
Atp1a2
ATPase, Na+/K+ transporting, alpha 2 polypeptide
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ATP1A2 mRNA
CTD
PMID:27935865
NCBI chr 1:172,099,276...172,125,631
Ensembl chr 1:172,099,276...172,125,631
G
Atp1a3
ATPase, Na+/K+ transporting, alpha 3 polypeptide
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of ATP1A3 mRNA
CTD
PMID:27935865
NCBI chr 7:24,677,592...24,705,338
Ensembl chr 7:24,677,592...24,705,383
G
Avpr1a
arginine vasopressin receptor 1A
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of AVPR1A mRNA
CTD
PMID:27935865
NCBI chr10:122,284,404...122,289,358
Ensembl chr10:122,284,404...122,289,357
G
B4galnt2
beta-1,4-N-acetyl-galactosaminyl transferase 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of B4GALNT2 mRNA
CTD
PMID:27935865
NCBI chr11:95,754,385...95,805,786
Ensembl chr11:95,756,769...95,805,717
G
Bend4
BEN domain containing 4
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of BEND4 mRNA
CTD
PMID:27935865
NCBI chr 5:67,549,490...67,585,471
Ensembl chr 5:67,549,490...67,585,653
G
Bhlha15
basic helix-loop-helix family, member a15
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BHLHA15 mRNA
CTD
PMID:27935865
NCBI chr 5:144,127,104...144,131,259
Ensembl chr 5:144,127,104...144,131,259
G
Bpifa5
BPI fold containing family A, member 5
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of BPIFA5 mRNA
CTD
PMID:27935865
NCBI chr 2:154,004,527...154,010,366
Ensembl chr 2:154,004,527...154,010,370
G
Bpifb1
BPI fold containing family B, member 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BPIFB1 mRNA
CTD
PMID:27935865
NCBI chr 2:154,032,738...154,062,263
Ensembl chr 2:154,032,738...154,062,289
G
Bricd5
BRICHOS domain containing 5
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BRICD5 mRNA
CTD
PMID:27935865
NCBI chr17:24,692,858...24,694,443
Ensembl chr17:24,692,858...24,694,443
G
Btn1a1
butyrophilin, subfamily 1, member A1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of BTN1A1 mRNA
CTD
PMID:27935865
NCBI chr13:23,641,154...23,650,084
Ensembl chr13:23,641,162...23,650,071
G
C1qtnf2
C1q and tumor necrosis factor related protein 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of C1QTNF2 mRNA
CTD
PMID:27935865
NCBI chr11:43,364,984...43,382,485
Ensembl chr11:43,365,103...43,382,352
G
C1qtnf7
C1q and tumor necrosis factor related protein 7
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of C1QTNF7 mRNA
CTD
PMID:27935865
NCBI chr 5:43,672,792...43,776,805
Ensembl chr 5:43,672,881...43,776,145
G
C5ar1
complement component 5a receptor 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of C5AR1 mRNA
CTD
PMID:27935865
NCBI chr 7:15,980,668...15,993,465
Ensembl chr 7:15,980,668...15,993,465
G
C5ar2
complement component 5a receptor 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of C5AR2 mRNA
CTD
PMID:27935865
NCBI chr 7:15,968,512...15,978,079
Ensembl chr 7:15,968,510...15,978,079
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CAMK2N1 mRNA]
CTD
PMID:29891994
NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434
G
Car3
carbonic anhydrase 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CAR3 mRNA
CTD
PMID:27935865
NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
G
Card10
caspase recruitment domain family, member 10
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CARD10 mRNA]
CTD
PMID:29891994
NCBI chr15:78,659,323...78,687,261
Ensembl chr15:78,659,338...78,687,242
G
Cbx4
chromobox 4
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CBX4 mRNA]
CTD
PMID:29891994
NCBI chr11:118,968,399...118,977,067
Ensembl chr11:118,968,399...118,977,047
G
Ccdc42
coiled-coil domain containing 42
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCDC42 mRNA
CTD
PMID:27935865
NCBI chr11:68,477,863...68,488,777
Ensembl chr11:68,477,847...68,488,792
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL2 mRNA
CTD
PMID:27935865
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl3
C-C motif chemokine ligand 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL3 mRNA
CTD
PMID:27935865
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccl7
C-C motif chemokine ligand 7
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CCL7 mRNA
CTD
PMID:27935865
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
G
Ccna1
cyclin A1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCNA1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CCNA1 mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922
G
Ccno
cyclin O
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CCNO mRNA
CTD
PMID:27935865
NCBI chr13:113,124,363...113,127,313
Ensembl chr13:113,124,336...113,127,311
G
Cd177
CD177 antigen
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CD177 mRNA
CTD
PMID:27935865
NCBI chr 7:24,443,408...24,459,759
Ensembl chr 7:24,443,408...24,459,736
G
Cd209f
CD209f antigen
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CD209F mRNA
CTD
PMID:27935865
NCBI chr 8:4,152,784...4,155,838
Ensembl chr 8:4,152,787...4,155,835
G
Cd5l
CD5 antigen-like
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CD5L mRNA
CTD
PMID:27935865
NCBI chr 3:87,265,188...87,278,381
Ensembl chr 3:87,265,188...87,278,380
G
Cdc20b
cell division cycle 20B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CDC20B mRNA
CTD
PMID:27935865
NCBI chr13:113,171,514...113,257,553
Ensembl chr13:113,171,645...113,227,729
G
Cdh26
cadherin-like 26
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CDH26 mRNA
CTD
PMID:27935865
NCBI chr 2:178,072,263...178,129,159
Ensembl chr 2:178,072,324...178,129,159
G
Cdhr1
cadherin-related family member 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CDHR1 mRNA
CTD
PMID:27935865
NCBI chr14:36,799,806...36,820,304
Ensembl chr14:36,799,814...36,820,304
G
Celsr3
cadherin, EGF LAG seven-pass G-type receptor 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CELSR3 mRNA
CTD
PMID:27935865
NCBI chr 9:108,703,244...108,730,168
Ensembl chr 9:108,703,519...108,730,168
G
Cfd
complement factor D
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CFD mRNA
CTD
PMID:27935865
NCBI chr10:79,726,687...79,728,489
Ensembl chr10:79,726,687...79,728,489
G
Chi3l1
chitinase 3 like 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CHI3L1 mRNA
CTD
PMID:27935865
NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
G
Chil4
chitinase-like 4
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CHIL4 mRNA
CTD
PMID:27935865
NCBI chr 3:106,108,807...106,126,795
Ensembl chr 3:106,108,806...106,126,823
G
Chodl
chondrolectin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHODL mRNA
CTD
PMID:27935865
NCBI chr16:78,727,729...78,748,624
Ensembl chr16:78,727,836...78,748,621
G
Chrdl1
chordin-like 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHRDL1 mRNA
CTD
PMID:27935865
NCBI chr X:142,068,670...142,177,282
Ensembl chr X:142,068,670...142,177,258
G
Chrm2
cholinergic receptor, muscarinic 2, cardiac
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHRM2 mRNA
CTD
PMID:27935865
NCBI chr 6:36,364,928...36,505,573
Ensembl chr 6:36,365,019...36,505,349
G
Cidec
cell death-inducing DFFA-like effector c
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CIDEC mRNA
CTD
PMID:27935865
NCBI chr 6:113,401,595...113,412,721
Ensembl chr 6:113,401,595...113,412,721
G
Ckmt2
creatine kinase, mitochondrial 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CKMT2 mRNA
CTD
PMID:27935865
NCBI chr13:92,001,510...92,025,001
Ensembl chr13:92,001,506...92,025,004
G
Clec4d
C-type lectin domain family 4, member d
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CLEC4D mRNA
CTD
PMID:27935865
NCBI chr 6:123,239,066...123,252,227
Ensembl chr 6:123,239,070...123,252,224
G
Clec4e
C-type lectin domain family 4, member e
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CLEC4E mRNA
CTD
PMID:27935865
NCBI chr 6:123,258,748...123,266,830
Ensembl chr 6:123,258,748...123,266,829
G
Cnn1
calponin 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CNN1 mRNA
CTD
PMID:27935865
NCBI chr 9:22,010,501...22,020,517
Ensembl chr 9:22,010,512...22,020,926
G
Cntfr
ciliary neurotrophic factor receptor
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CNTFR mRNA
CTD
PMID:27935865
NCBI chr 4:41,657,498...41,697,091
Ensembl chr 4:41,657,498...41,697,089
G
Colq
collagen like tail subunit of asymmetric acetylcholinesterase
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of COLQ mRNA
CTD
PMID:27935865
NCBI chr14:31,245,039...31,299,820
Ensembl chr14:31,245,039...31,313,300
G
Cox7a1
cytochrome c oxidase subunit 7A1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of COX7A1 mRNA
CTD
PMID:27935865
NCBI chr 7:29,883,596...29,885,455
Ensembl chr 7:29,883,569...29,885,503
G
Cplx1
complexin 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CPLX1 mRNA
CTD
PMID:27935865
NCBI chr 5:108,666,420...108,697,893
Ensembl chr 5:108,666,420...108,697,890
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CREB1 mRNA]
CTD
PMID:29891994
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Creb3l3
cAMP responsive element binding protein 3-like 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CREB3L3 mRNA
CTD
PMID:27935865
NCBI chr10:80,920,163...80,934,706
Ensembl chr10:80,920,158...80,934,708
G
Crisp3
cysteine-rich secretory protein 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CRISP3 mRNA
CTD
PMID:27935865
NCBI chr17:40,532,668...40,553,179
Ensembl chr17:40,532,668...40,553,179
G
Crispld1
cysteine-rich secretory protein LCCL domain containing 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CRISPLD1 mRNA
CTD
PMID:27935865
NCBI chr 1:17,797,276...17,840,350
Ensembl chr 1:17,797,269...17,836,568
G
Crxos
cone-rod homeobox, opposite strand
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CRXOS mRNA
CTD
PMID:27935865
NCBI chr 7:15,616,542...15,637,945
Ensembl chr 7:15,616,542...15,637,945
G
Cryl1
crystallin, lambda 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CRYL1 mRNA]
CTD
PMID:29891994
NCBI chr14:57,512,491...57,635,940
Ensembl chr14:57,512,450...57,635,986
G
Csf3
colony stimulating factor 3 (granulocyte)
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CSF3 mRNA
CTD
PMID:27935865
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
G
Csf3r
colony stimulating factor 3 receptor
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CSF3R mRNA
CTD
PMID:27935865
NCBI chr 4:125,917,241...125,938,233
Ensembl chr 4:125,918,343...125,938,233
G
Csrp1
cysteine and glycine-rich protein 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CSRP1 mRNA]
CTD
PMID:29891994
NCBI chr 1:135,614,650...135,679,970
Ensembl chr 1:135,647,799...135,679,970
G
Ctsc
cathepsin C
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of CTSC mRNA]
CTD
PMID:29891994
NCBI chr 7:87,927,233...87,960,083
Ensembl chr 7:87,927,293...87,960,096
G
Cxcl12
C-X-C motif chemokine ligand 12
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CXCL12 mRNA
CTD
PMID:27935865
NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328
G
Cxcl15
C-X-C motif chemokine ligand 15
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL5 mRNA
CTD
PMID:27935865
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL2 mRNA
CTD
PMID:27935865
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCL3 mRNA
CTD
PMID:27935865
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cxcr2
C-X-C motif chemokine receptor 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CXCR2 mRNA
CTD
PMID:27935865
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
G
Cyp2d9
cytochrome P450, family 2, subfamily d, polypeptide 9
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYP2D9 mRNA
CTD
PMID:27935865
NCBI chr15:82,336,578...82,341,028
Ensembl chr15:82,317,638...82,341,046
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYP2E1 mRNA
CTD
PMID:27935865
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp4a12a
cytochrome P450, family 4, subfamily a, polypeptide 12a
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYP4A12A mRNA
CTD
PMID:27935865
NCBI chr 4:115,156,243...115,190,012
Ensembl chr 4:115,156,243...115,190,012
G
Cyp4f18
cytochrome P450, family 4, subfamily f, polypeptide 18
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of CYP4F18 mRNA
CTD
PMID:27935865
NCBI chr 8:72,742,326...72,763,512
Ensembl chr 8:72,742,326...72,763,470
G
Cys1
cystin 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CYS1 mRNA
CTD
PMID:27935865
NCBI chr12:24,715,832...24,731,794
Ensembl chr12:24,715,832...24,731,812
G
Dcaf12l1
DDB1 and CUL4 associated factor 12-like 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCAF12L1 mRNA
CTD
PMID:27935865
NCBI chr X:43,875,444...43,879,074
Ensembl chr X:43,875,447...43,879,074
G
Dchs1
dachsous cadherin related 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCHS1 mRNA
CTD
PMID:27935865
NCBI chr 7:105,402,196...105,437,562
Ensembl chr 7:105,402,197...105,436,861
G
Dcpp1
demilune cell and parotid protein 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCPP1 mRNA
CTD
PMID:27935865
NCBI chr17:24,099,643...24,101,827
Ensembl chr17:24,099,850...24,101,827
G
Dcpp2
demilune cell and parotid protein 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCPP2 mRNA
CTD
PMID:27935865
NCBI chr17:24,117,696...24,119,762
Ensembl chr17:24,099,854...24,119,762
G
Dcpp3
demilune cell and parotid protein 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DCPP3 mRNA
CTD
PMID:27935865
NCBI chr17:24,136,432...24,138,415
Ensembl chr17:24,136,432...24,138,415
G
Defb3
defensin beta 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of DEFB3 mRNA
CTD
PMID:27935865
NCBI chr 8:19,343,377...19,345,355
Ensembl chr 8:19,343,376...19,345,307
G
Degs2
delta 4-desaturase, sphingolipid 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of DEGS2 mRNA
CTD
PMID:27935865
NCBI chr12:108,653,051...108,668,561
Ensembl chr12:108,644,970...108,668,570
G
Derl3
Der1-like domain family, member 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DERL3 mRNA
CTD
PMID:27935865
NCBI chr10:75,729,232...75,731,775
Ensembl chr10:75,729,247...75,731,775
G
Dhdh
dihydrodiol dehydrogenase
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of DHDH mRNA]
CTD
PMID:29891994
NCBI chr 7:45,122,380...45,138,312
Ensembl chr 7:45,120,411...45,138,229
G
Dmbt1
deleted in malignant brain tumors 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DMBT1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of DMBT1 mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr 7:130,633,787...130,723,357
Ensembl chr 7:130,633,776...130,723,357
G
Dmrta1
doublesex and mab-3 related transcription factor like family A1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DMRTA1 mRNA
CTD
PMID:27935865
NCBI chr 4:89,576,435...89,583,003
Ensembl chr 4:89,567,673...89,583,009
G
Dpt
dermatopontin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DPT mRNA
CTD
PMID:27935865
NCBI chr 1:164,624,232...164,651,843
Ensembl chr 1:164,624,213...164,651,835
G
Drd1
dopamine receptor D1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of DRD1 mRNA
CTD
PMID:27935865
NCBI chr13:54,205,202...54,209,677
Ensembl chr13:54,205,202...54,209,724
G
Edn3
endothelin 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EDN3 mRNA
CTD
PMID:27935865
NCBI chr 2:174,602,412...174,625,835
Ensembl chr 2:174,602,412...174,625,835
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of EEF1A2 mRNA]
CTD
PMID:29891994
NCBI chr 2:180,783,551...180,798,808
Ensembl chr 2:180,789,446...180,798,807
G
Egf
epidermal growth factor
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EGF mRNA
CTD
PMID:27935865
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
G
Epha3
Eph receptor A3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPHA3 mRNA
CTD
PMID:27935865
NCBI chr16:63,363,895...63,684,538
Ensembl chr16:63,363,897...63,684,538
G
Epha5
Eph receptor A5
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPHA5 mRNA
CTD
PMID:27935865
NCBI chr 5:84,199,024...84,565,677
Ensembl chr 5:84,202,620...84,565,241
G
Epyc
epiphycan
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of EPYC mRNA
CTD
PMID:27935865
NCBI chr10:97,479,930...97,517,770
Ensembl chr10:97,479,930...97,518,316
G
F2rl1
F2R like trypsin receptor 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of F2RL1 mRNA]
CTD
PMID:29891994
NCBI chr13:95,648,226...95,661,748
Ensembl chr13:95,648,240...95,661,735
G
F2rl3
F2R like thrombin or trypsin receptor 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of F2RL3 mRNA
CTD
PMID:27935865
NCBI chr 8:73,488,287...73,490,526
Ensembl chr 8:73,488,508...73,490,502
G
F3
coagulation factor III
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of F3 mRNA]
CTD
PMID:29891994
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
Fam13c
family with sequence similarity 13, member C
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FAM13C mRNA
CTD
PMID:27935865
NCBI chr10:70,274,981...70,394,566
Ensembl chr10:70,276,311...70,394,566
G
Fam240b
family with sequence similarity 240 member B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FAM240B mRNA
CTD
PMID:27935865
NCBI chr13:64,629,060...64,645,606
Ensembl chr13:64,629,060...64,645,606
G
Fat2
FAT atypical cadherin 2
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FAT2 mRNA]
CTD
PMID:29891994
NCBI chr11:55,141,435...55,228,331
Ensembl chr11:55,141,435...55,227,390
G
Fbln7
fibulin 7
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FBLN7 mRNA
CTD
PMID:27935865
NCBI chr 2:128,705,791...128,738,954
Ensembl chr 2:128,704,901...128,738,954
G
Fbxo40
F-box protein 40
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FBXO40 mRNA
CTD
PMID:27935865
NCBI chr16:36,783,823...36,811,321
Ensembl chr16:36,783,822...36,810,829
G
Fcrl2
Fc receptor like 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FCRL2 mRNA
CTD
PMID:27935865
NCBI chr 3:87,158,318...87,171,046
Ensembl chr 3:87,158,065...87,171,045
G
Fhod3
formin homology 2 domain containing 3
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of FHOD3 mRNA]
CTD
PMID:29891994
NCBI chr18:24,841,445...25,266,564
Ensembl chr18:24,841,680...25,266,558
G
Foxn4
forkhead box N4
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FOXN4 mRNA
CTD
PMID:27935865
NCBI chr 5:114,392,225...114,412,486
Ensembl chr 5:114,392,225...114,411,868
G
Fpr2
formyl peptide receptor 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of FPR2 mRNA
CTD
PMID:27935865
NCBI chr17:18,108,086...18,114,214
Ensembl chr17:18,108,086...18,114,214
G
Frem1
Fras1 related extracellular matrix protein 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FREM1 mRNA
CTD
PMID:27935865
NCBI chr 4:82,816,157...82,970,743
Ensembl chr 4:82,816,164...82,970,576
G
Frmpd4
FERM and PDZ domain containing 4
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FRMPD4 mRNA
CTD
PMID:27935865
NCBI chr X:166,254,297...167,360,230
Ensembl chr X:166,254,305...167,360,227
G
Frzb
frizzled-related protein
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of FRZB mRNA
CTD
PMID:27935865
NCBI chr 2:80,242,314...80,277,740
Ensembl chr 2:80,242,314...80,277,969
G
Gabra4
gamma-aminobutyric acid type A receptor subunit alpha 4
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GABRA4 mRNA
CTD
PMID:27935865
NCBI chr 5:71,727,077...71,815,651
Ensembl chr 5:71,727,092...71,815,651
G
Gal3st2
galactose-3-O-sulfotransferase 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of GAL3ST2 mRNA
CTD
PMID:27935865
NCBI chr 1:93,789,066...93,804,220
Ensembl chr 1:93,789,028...93,804,216
G
Gask1a
golgi associated kinase 1A
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GASK1A mRNA
CTD
PMID:27935865
NCBI chr 9:121,780,057...121,817,379
Ensembl chr 9:121,780,054...121,809,275
G
Gcnt4
glucosaminyl (N-acetyl) transferase 4, core 2 (beta-1,6-N-acetylglucosaminyltransferase)
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of GCNT4 mRNA
CTD
PMID:27935865
NCBI chr13:97,060,852...97,087,422
Ensembl chr13:97,061,197...97,087,414
G
Gdf10
growth differentiation factor 10
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GDF10 mRNA
CTD
PMID:27935865
NCBI chr14:33,645,544...33,658,471
Ensembl chr14:33,645,544...33,659,940
G
Gfra3
glial cell line derived neurotrophic factor family receptor alpha 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GFRA3 mRNA
CTD
PMID:27935865
NCBI chr18:34,822,951...34,853,440
Ensembl chr18:34,822,951...34,853,440
G
Gja3
gap junction protein, alpha 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GJA3 mRNA
CTD
PMID:27935865
NCBI chr14:57,271,917...57,295,487
Ensembl chr14:57,271,917...57,295,557
G
Gprasp2
G protein-coupled receptor associated sorting protein 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of GPRASP2 mRNA
CTD
PMID:27935865
NCBI chr X:134,739,786...134,745,480
Ensembl chr X:134,739,783...134,745,479
G
Gstk1
glutathione S-transferase kappa 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of GSTK1 mRNA]
CTD
PMID:29891994
NCBI chr 6:42,222,869...42,227,375
Ensembl chr 6:42,222,869...42,227,381
G
Gstz1
glutathione transferase zeta 1 (maleylacetoacetate isomerase)
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of GSTZ1 mRNA]
CTD
PMID:29891994
NCBI chr12:87,192,102...87,211,497
Ensembl chr12:87,193,939...87,211,497
G
Hes1
hes family bHLH transcription factor 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HES1 mRNA]
CTD
PMID:29891994
NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
G
Hhip
Hedgehog-interacting protein
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of HHIP mRNA
CTD
PMID:27935865
NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635
G
Hsd17b8
hydroxysteroid 17-beta dehydrogenase 8
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of HSD17B8 mRNA]
CTD
PMID:29891994
NCBI chr17:34,245,007...34,247,029
Ensembl chr17:34,245,007...34,247,034
G
Htr2b
5-hydroxytryptamine (serotonin) receptor 2B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of HTR2B mRNA
CTD
PMID:27935865
NCBI chr 1:86,025,268...86,043,960
Ensembl chr 1:86,026,748...86,039,692
G
Idh2
isocitrate dehydrogenase 2 (NADP+), mitochondrial
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IDH2 mRNA]
CTD
PMID:29891994
NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140
G
Ido1
indoleamine 2,3-dioxygenase 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of IDO1 mRNA
CTD
PMID:27935865
NCBI chr 8:25,074,148...25,086,987
Ensembl chr 8:25,074,152...25,087,025
G
Ifi27l2a
interferon, alpha-inducible protein 27 like 2A
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IFI27L2 mRNA]
CTD
PMID:29891994
NCBI chr12:103,400,132...103,409,939
Ensembl chr12:103,408,426...103,409,939
G
Ifitm6
interferon induced transmembrane protein 6
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IFITM6 mRNA
CTD
PMID:27935865
NCBI chr 7:140,595,725...140,596,805
Ensembl chr 7:140,595,612...140,597,837
G
Igll1
immunoglobulin lambda-like polypeptide 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IGLL1 mRNA
CTD
PMID:27935865
NCBI chr16:16,678,535...16,681,849
Ensembl chr16:16,678,535...16,681,849
G
Iigp1
interferon inducible GTPase 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of IIGP1 mRNA
CTD
PMID:27935865
NCBI chr18:60,506,688...60,525,706
Ensembl chr18:60,509,099...60,525,706
G
Il19
interleukin 19
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IL19 mRNA
CTD
PMID:27935865
NCBI chr 1:130,860,393...130,873,194
Ensembl chr 1:130,860,393...130,867,852
G
Il1b
interleukin 1 beta
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of IL1B mRNA
CTD
PMID:27935865
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Inmt
indolethylamine N-methyltransferase
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of INMT mRNA
CTD
PMID:27935865
NCBI chr 6:55,147,612...55,151,975
Ensembl chr 6:55,147,611...55,152,028
G
Irf7
interferon regulatory factor 7
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IRF7 mRNA]
CTD
PMID:29891994
NCBI chr 7:140,843,096...140,846,412
Ensembl chr 7:140,842,619...140,846,394
G
Irs2
insulin receptor substrate 2
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of IRS2 mRNA]
CTD
PMID:29891994
NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458
G
Isg15
ISG15 ubiquitin-like modifier
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ISG15 mRNA]
CTD
PMID:29891994
NCBI chr 4:156,283,881...156,285,275
Ensembl chr 4:156,283,912...156,285,253
G
Itpr1
inositol 1,4,5-trisphosphate receptor 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ITPR1 mRNA]
CTD
PMID:29891994
NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070
G
Itpr3
inositol 1,4,5-triphosphate receptor 3
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ITPR3 mRNA]
CTD
PMID:29891994
NCBI chr17:27,275,976...27,341,197
Ensembl chr17:27,276,278...27,341,197
G
Jchain
immunoglobulin joining chain
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of JCHAIN mRNA
CTD
PMID:27935865
NCBI chr 5:88,667,663...88,675,667
Ensembl chr 5:88,667,668...88,675,750
G
Kank4
KN motif and ankyrin repeat domains 4
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KANK4 mRNA
CTD
PMID:27935865
NCBI chr 4:98,643,129...98,706,295
Ensembl chr 4:98,643,135...98,705,774
G
Kbtbd12
kelch repeat and BTB (POZ) domain containing 12
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KBTBD12 mRNA
CTD
PMID:27935865
NCBI chr 6:88,521,931...88,604,636
Ensembl chr 6:88,522,096...88,614,932
G
Kcna1
potassium voltage-gated channel, shaker-related subfamily, member 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KCNA1 mRNA
CTD
PMID:27935865
NCBI chr 6:126,613,426...126,622,764
Ensembl chr 6:126,617,360...126,623,347
G
Kcnma1
potassium large conductance calcium-activated channel, subfamily M, alpha member 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KCNMA1 mRNA
CTD
PMID:27935865
NCBI chr14:23,342,356...24,055,173
Ensembl chr14:23,339,499...24,064,559
G
Klhl13
kelch-like 13
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL13 mRNA
CTD
PMID:27935865
NCBI chr X:23,085,510...23,231,340
Ensembl chr X:23,085,510...23,231,321
G
Klhl33
kelch-like 33
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL33 mRNA
CTD
PMID:27935865
NCBI chr14:51,126,038...51,134,940
Ensembl chr14:51,126,039...51,134,964
G
Klhl4
kelch-like 4
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of KLHL4 mRNA
CTD
PMID:27935865
NCBI chr X:113,384,030...113,470,826
Ensembl chr X:113,384,030...113,470,526
G
Klk6
kallikrein related-peptidase 6
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KLK6 mRNA
CTD
PMID:27935865
NCBI chr 7:43,473,967...43,481,219
Ensembl chr 7:43,473,923...43,481,454
G
Kng2
kininogen 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KNG2 mRNA
CTD
PMID:27935865
NCBI chr16:22,804,602...22,847,851
Ensembl chr16:22,804,604...22,848,232
G
Krt16
keratin 16
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KRT16 mRNA
CTD
PMID:27935865
NCBI chr11:100,136,917...100,139,728
Ensembl chr11:100,136,917...100,139,728
G
Krt6b
keratin 6B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KRT6B mRNA
CTD
PMID:27935865
NCBI chr15:101,584,458...101,588,728
Ensembl chr15:101,584,458...101,588,722
G
Krt84
keratin 84
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of KRT84 mRNA
CTD
PMID:27935865
NCBI chr15:101,433,461...101,441,255
Ensembl chr15:101,433,461...101,441,255
G
Letmd1
LETM1 domain containing 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LETMD1 mRNA]
CTD
PMID:29891994
NCBI chr15:100,360,302...100,377,133
Ensembl chr15:100,366,904...100,377,045
G
Lin28a
lin-28 homolog A
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LIN28A mRNA
CTD
PMID:27935865
NCBI chr 4:133,730,641...133,746,504
Ensembl chr 4:133,730,641...133,746,152
G
Lipf
lipase, gastric
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LIPF mRNA
CTD
PMID:27935865
NCBI chr19:33,938,648...33,954,213
Ensembl chr19:33,938,587...33,954,210
G
Lipn
lipase, family member N
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LIPN mRNA
CTD
PMID:27935865
NCBI chr19:34,044,458...34,063,346
Ensembl chr19:34,044,758...34,062,318
G
Lman1l
lectin, mannose-binding 1 like
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LMAN1L mRNA
CTD
PMID:27935865
NCBI chr 9:57,514,080...57,528,057
Ensembl chr 9:57,514,368...57,528,057
G
Lmntd1
lamin tail domain containing 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LMNTD1 mRNA
CTD
PMID:27935865
NCBI chr 6:145,311,619...145,560,045
Ensembl chr 6:145,310,860...145,560,045
G
Lmo4
LIM domain only 4
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of LMO4 mRNA]
CTD
PMID:29891994
NCBI chr 3:143,894,291...143,911,016
Ensembl chr 3:143,894,291...143,910,981
G
Lmod3
leiomodin 3 (fetal)
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LMOD3 mRNA
CTD
PMID:27935865
NCBI chr 6:97,215,491...97,230,137
Ensembl chr 6:97,215,495...97,229,720
G
Lrg1
leucine-rich alpha-2-glycoprotein 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LRG1 mRNA
CTD
PMID:27935865
NCBI chr17:56,426,678...56,428,946
Ensembl chr17:56,426,678...56,429,001
G
Lrrc3b
leucine rich repeat containing 3B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LRRC3B mRNA
CTD
PMID:27935865
NCBI chr14:7,030,776...7,112,248
Ensembl chr14:7,030,776...7,112,248
G
Lrrc4b
leucine rich repeat containing 4B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of LRRC4B mRNA
CTD
PMID:27935865
NCBI chr 7:44,091,911...44,112,775
Ensembl chr 7:44,078,442...44,112,775
G
Mamstr
MEF2 activating motif and SAP domain containing transcriptional regulator
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MAMSTR mRNA
CTD
PMID:27935865
NCBI chr 7:45,288,616...45,297,631
Ensembl chr 7:45,289,401...45,295,945
G
Map1lc3a
microtubule-associated protein 1 light chain 3 alpha
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of MAP1LC3A mRNA]
CTD
PMID:29891994
NCBI chr 2:155,118,284...155,119,993
Ensembl chr 2:155,118,217...155,119,993
G
Mcidas
multiciliate differentiation and DNA synthesis associated cell cycle protein
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MCIDAS mRNA
CTD
PMID:27935865
NCBI chr13:113,130,104...113,138,233
Ensembl chr13:113,130,379...113,136,928
G
Mfap4
microfibrillar-associated protein 4
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MFAP4 mRNA
CTD
PMID:27935865
NCBI chr11:61,376,257...61,379,536
Ensembl chr11:61,376,257...61,379,726
G
Mgam
maltase-glucoamylase
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MGAM mRNA
CTD
PMID:27935865
NCBI chr 6:40,605,765...40,746,057
Ensembl chr 6:40,605,765...40,746,057
G
Mirt2
myocardial infraction associated transcript 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MIRT2 mRNA
CTD
PMID:27935865
NCBI chr15:76,150,987...76,154,039
Ensembl chr15:76,150,661...76,154,039
G
Mme
membrane metallo endopeptidase
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MME mRNA
CTD
PMID:27935865
NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451
G
Mmp10
matrix metallopeptidase 10
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MMP10 mRNA
CTD
PMID:27935865
NCBI chr 9:7,502,343...7,510,243
Ensembl chr 9:7,502,353...7,510,241
G
Mmp8
matrix metallopeptidase 8
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MMP8 mRNA
CTD
PMID:27935865
NCBI chr 9:7,558,430...7,568,487
Ensembl chr 9:7,558,457...7,568,486
G
Mrgpra2b
MAS-related GPR, member A2B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MRGPRA2B mRNA
CTD
PMID:27935865
NCBI chr 7:47,113,555...47,139,330
Ensembl chr 7:47,113,554...47,178,610
G
Mstn
myostatin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MSTN mRNA
CTD
PMID:27935865
NCBI chr 1:53,100,799...53,107,238
Ensembl chr 1:53,100,799...53,107,238
G
Msx3
msh homeobox 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of MSX3 mRNA
CTD
PMID:27935865
NCBI chr 7:139,626,070...139,629,001
Ensembl chr 7:139,626,070...139,629,002
G
Musk
muscle, skeletal, receptor tyrosine kinase
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MUSK mRNA
CTD
PMID:27935865
NCBI chr 4:58,285,742...58,377,848
Ensembl chr 4:58,285,962...58,374,303
G
Myadml2
myeloid-associated differentiation marker-like 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYADML2 mRNA
CTD
PMID:27935865
NCBI chr11:120,536,857...120,539,188
Ensembl chr11:120,536,857...120,538,984
G
Myh13
myosin, heavy polypeptide 13, skeletal muscle
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYH13 mRNA
CTD
PMID:27935865
NCBI chr11:67,217,929...67,262,413
Ensembl chr11:67,212,484...67,262,412
G
Myoc
myocilin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOC mRNA
CTD
PMID:27935865
NCBI chr 1:162,466,719...162,477,263
Ensembl chr 1:162,466,724...162,477,262
G
Myocd
myocardin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOCD mRNA
CTD
PMID:27935865
NCBI chr11:65,064,434...65,160,821
Ensembl chr11:65,067,387...65,160,815
G
Myog
myogenin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOG mRNA
CTD
PMID:27935865
NCBI chr 1:134,217,742...134,220,286
Ensembl chr 1:134,217,727...134,220,286
G
Myoz3
myozenin 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of MYOZ3 mRNA
CTD
PMID:27935865
NCBI chr18:60,706,789...60,724,931
Ensembl chr18:60,706,822...60,724,860
G
Nags
N-acetylglutamate synthase
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NAGS mRNA
CTD
PMID:27935865
NCBI chr11:102,036,339...102,040,354
Ensembl chr11:102,036,339...102,040,303
G
Nell2
NEL-like 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NELL2 mRNA
CTD
PMID:27935865
NCBI chr15:95,117,321...95,426,677
Ensembl chr15:94,973,111...95,426,440
G
Nfe2
nuclear factor, erythroid derived 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NFE2 mRNA
CTD
PMID:27935865
NCBI chr15:103,156,640...103,166,809
Ensembl chr15:103,156,639...103,166,830
G
Ngp
neutrophilic granule protein
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NGP mRNA
CTD
PMID:27935865
NCBI chr 9:110,248,876...110,252,080
Ensembl chr 9:110,248,815...110,252,080
G
Nkx2-9
NK2 homeobox 9
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NKX2-9 mRNA
CTD
PMID:27935865
NCBI chr12:56,658,174...56,660,354
Ensembl chr12:56,658,174...56,660,069
G
Nkx3-1
NK3 homeobox 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of NKX3-1 mRNA
CTD
PMID:27935865
NCBI chr14:69,428,141...69,432,107
Ensembl chr14:69,428,087...69,432,111
G
Nlrp12
NLR family, pyrin domain containing 12
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NLRP12 mRNA
CTD
PMID:27935865
NCBI chr 7:3,267,317...3,298,400
Ensembl chr 7:3,267,458...3,298,370
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NLRP3 mRNA
CTD
PMID:27935865
NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782
G
Npy
neuropeptide Y
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of NPY mRNA
CTD
PMID:27935865
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
G
Ntf3
neurotrophin 3
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of NTF3 mRNA]
CTD
PMID:29891994
NCBI chr 6:126,078,375...126,143,703
Ensembl chr 6:126,078,375...126,143,873
G
Olfml1
olfactomedin-like 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of OLFML1 mRNA
CTD
PMID:27935865
NCBI chr 7:107,166,640...107,190,572
Ensembl chr 7:107,166,653...107,190,301
G
Opcml
opioid binding protein/cell adhesion molecule-like
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of OPCML mRNA
CTD
PMID:27935865
NCBI chr 9:27,702,050...28,836,706
Ensembl chr 9:27,702,071...28,836,706
G
Otop2
otopetrin 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of OTOP2 mRNA
CTD
PMID:27935865
NCBI chr11:115,197,989...115,223,132
Ensembl chr11:115,197,989...115,223,129
G
P2rx4
purinergic receptor P2X, ligand-gated ion channel 4
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of P2RX4 mRNA]
CTD
PMID:29891994
NCBI chr 5:122,845,581...122,867,802
Ensembl chr 5:122,845,607...122,867,801
G
Pax1
paired box 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PAX1 mRNA
CTD
PMID:27935865
NCBI chr 2:147,203,850...147,216,972
Ensembl chr 2:147,203,845...147,235,215
G
Pax7
paired box 7
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PAX7 mRNA
CTD
PMID:27935865
NCBI chr 4:139,464,357...139,560,841
Ensembl chr 4:139,464,373...139,560,839
G
Pck1
phosphoenolpyruvate carboxykinase 1, cytosolic
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PCK1 mRNA
CTD
PMID:27935865
NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
G
Pck2
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PCK2 mRNA]
CTD
PMID:29891994
NCBI chr14:55,777,721...55,787,477
Ensembl chr14:55,777,723...55,788,699
G
Pde3a
phosphodiesterase 3A, cGMP inhibited
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PDE3A mRNA
CTD
PMID:27935865
NCBI chr 6:141,194,995...141,452,588
Ensembl chr 6:141,194,995...141,453,174
G
Perm1
PPARGC1 and ESRR induced regulator, muscle 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PERM1 mRNA
CTD
PMID:27935865
NCBI chr 4:156,287,724...156,305,766
Ensembl chr 4:156,300,325...156,305,764
G
Pgm5
phosphoglucomutase 5
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PGM5 mRNA
CTD
PMID:27935865
NCBI chr19:24,655,625...24,839,206
Ensembl chr19:24,660,380...24,839,219
G
Pgr
progesterone receptor
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PGR mRNA
CTD
PMID:27935865
NCBI chr 9:8,890,017...8,968,612
Ensembl chr 9:8,899,834...8,968,612
G
Phex
phosphate regulating endopeptidase homolog, X-linked
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PHEX mRNA
CTD
PMID:27935865
NCBI chr X:155,945,071...156,198,282
Ensembl chr X:155,945,071...156,198,308
G
Pira2
paired-Ig-like receptor A2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of LILRA6 mRNA
CTD
PMID:27935865
NCBI chr 7:3,839,807...3,848,102
Ensembl chr 7:3,839,811...3,848,050
G
Pitx2
paired-like homeodomain transcription factor 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PITX2 mRNA
CTD
PMID:27935865
NCBI chr 3:128,993,527...129,013,243
Ensembl chr 3:128,993,527...129,013,240
G
Pkhd1l1
polycystic kidney and hepatic disease 1-like 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PKHD1L1 mRNA
CTD
PMID:27935865
NCBI chr15:44,320,792...44,464,772
Ensembl chr15:44,320,890...44,464,765
G
Pkn1
protein kinase N1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PKN1 mRNA]
CTD
PMID:29891994
NCBI chr 8:84,393,162...84,425,819
Ensembl chr 8:84,393,165...84,425,808
G
Plcb4
phospholipase C, beta 4
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PLCB4 mRNA]
CTD
PMID:29891994
NCBI chr 2:135,500,523...135,856,522
Ensembl chr 2:135,500,931...135,856,513
G
Plin1
perilipin 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PLIN1 mRNA
CTD
PMID:27935865
NCBI chr 7:79,370,912...79,382,652
Ensembl chr 7:79,369,966...79,382,651
G
Polr1h
RNA polymerase I subunit H
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of POLR1H mRNA]
CTD
PMID:29891994
NCBI chr17:37,265,250...37,269,417
Ensembl chr17:37,265,248...37,269,451
G
Ppbp
pro-platelet basic protein
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PPBP mRNA
CTD
PMID:27935865
NCBI chr 5:90,916,377...90,917,922
Ensembl chr 5:90,916,377...90,917,922
G
Prap1
proline-rich acidic protein 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PRAP1 mRNA
CTD
PMID:27935865
NCBI chr 7:139,673,309...139,677,116
Ensembl chr 7:139,673,308...139,677,113
G
Prdm6
PR domain containing 6
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PRDM6 mRNA
CTD
PMID:27935865
NCBI chr18:53,597,027...53,708,976
Ensembl chr18:53,596,655...53,708,979
G
Prok2
prokineticin 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PROK2 mRNA
CTD
PMID:27935865
NCBI chr 6:99,687,833...99,703,368
Ensembl chr 6:99,688,260...99,703,353
G
Prr32
proline rich 32
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PRR32 mRNA
CTD
PMID:27935865
NCBI chr X:44,179,805...44,181,668
Ensembl chr X:44,179,781...44,181,668
G
Prss2
serine protease 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PRSS2 mRNA
CTD
PMID:27935865
NCBI chr 6:41,498,710...41,502,013
Ensembl chr 6:41,498,721...41,502,013
G
Psors1c2
psoriasis susceptibility 1 candidate 2 (human)
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of PSORS1C2 mRNA
CTD
PMID:27935865
NCBI chr17:35,842,462...35,845,544
Ensembl chr17:35,844,098...35,845,544
G
Ptgdr
prostaglandin D receptor
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PTGDR mRNA
CTD
PMID:27935865
NCBI chr14:45,088,692...45,096,832
Ensembl chr14:45,088,692...45,096,832
G
Ptgfr
prostaglandin F receptor
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PTGFR mRNA
CTD
PMID:27935865
NCBI chr 3:151,504,247...151,543,165
Ensembl chr 3:151,502,139...151,543,267
G
Pwwp2b
PWWP domain containing 2B
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PWWP2B mRNA]
CTD
PMID:29891994
NCBI chr 7:138,828,398...138,847,172
Ensembl chr 7:138,828,398...138,849,819
G
Pxmp2
peroxisomal membrane protein 2
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PXMP2 mRNA]
CTD
PMID:29891994
NCBI chr 5:110,422,152...110,434,036
Ensembl chr 5:110,422,148...110,434,052
G
Pycr1
pyrroline-5-carboxylate reductase 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of PYCR1 mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of PYCR1 mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr11:120,527,591...120,534,602
Ensembl chr11:120,526,538...120,534,595
G
Rab17
RAB17, member RAS oncogene family
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAB17 mRNA]
CTD
PMID:29891994
NCBI chr 1:90,885,855...90,897,395
Ensembl chr 1:90,885,855...90,897,383
G
Rab2b
RAB2B, member RAS oncogene family
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAB2B mRNA]
CTD
PMID:29891994
NCBI chr14:52,499,216...52,516,852
Ensembl chr14:52,499,216...52,517,002
G
Rap1gap
Rap1 GTPase-activating protein
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RAP1GAP mRNA]
CTD
PMID:29891994
NCBI chr 4:137,391,549...137,457,172
Ensembl chr 4:137,392,037...137,457,172
G
Rasd2
RASD family, member 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RASD2 mRNA
CTD
PMID:27935865
NCBI chr 8:75,940,572...75,950,741
Ensembl chr 8:75,940,572...75,950,741
G
Rcan2
regulator of calcineurin 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RCAN2 mRNA
CTD
PMID:27935865
NCBI chr17:44,112,243...44,350,407
Ensembl chr17:44,112,242...44,350,407
G
Rdm1
RAD52 motif 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RDM1 mRNA]
CTD
PMID:29891994
NCBI chr11:101,517,992...101,526,926
Ensembl chr11:101,518,021...101,526,926
G
Retn
resistin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RETN mRNA
CTD
PMID:27935865
NCBI chr 8:3,705,770...3,709,818
Ensembl chr 8:3,705,770...3,710,110
G
Retnla
resistin like alpha
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RETNLA mRNA
CTD
PMID:27935865
NCBI chr16:48,662,972...48,664,824
Ensembl chr16:48,662,914...48,664,824
G
Retnlg
resistin like gamma
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of RETNLG mRNA
CTD
PMID:27935865
NCBI chr16:48,692,971...48,694,861
Ensembl chr16:48,692,984...48,694,859
G
Ripply1
ripply transcriptional repressor 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RIPPLY1 mRNA
CTD
PMID:27935865
NCBI chr X:138,680,430...138,683,102
Ensembl chr X:138,680,298...138,683,102
G
Rnase2b
ribonuclease, RNase A family, 2B (liver, eosinophil-derived neurotoxin)
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of RNASE2B mRNA
CTD
PMID:27935865
NCBI chr14:51,399,717...51,400,475
Ensembl chr14:51,399,717...51,400,475
G
Robo4
roundabout guidance receptor 4
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ROBO4 mRNA
CTD
PMID:27935865
NCBI chr 9:37,313,198...37,325,319
Ensembl chr 9:37,313,193...37,326,411
G
Rras
related RAS viral (r-ras) oncogene
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RRAS mRNA]
CTD
PMID:29891994
NCBI chr 7:44,665,686...44,671,070
Ensembl chr 7:44,667,385...44,671,071
G
Rtl3
retrotransposon Gag like 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RTL3 mRNA
CTD
PMID:27935865
NCBI chr X:105,880,688...105,884,145
Ensembl chr X:105,880,688...105,884,250
G
Rtl8a
retrotransposon Gag like 8A
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of RTL8A mRNA]
CTD
PMID:29891994
NCBI chr X:52,644,455...52,645,730
Ensembl chr X:52,644,455...52,645,649
G
Runx1t1
RUNX1 translocation partner 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of RUNX1T1 mRNA
CTD
PMID:27935865
NCBI chr 4:13,742,628...13,895,056
Ensembl chr 4:13,743,436...13,893,649
G
S100a8
S100 calcium binding protein A8 (calgranulin A)
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of S100A8 mRNA
CTD
PMID:27935865
NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
G
S100a9
S100 calcium binding protein A9 (calgranulin B)
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of S100A9 mRNA
CTD
PMID:27935865
NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028
G
Saa3
serum amyloid A 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SAA3 mRNA
CTD
PMID:27935865
NCBI chr 7:46,361,422...46,365,100
Ensembl chr 7:46,361,422...46,365,124
G
Samsn1
SAM domain, SH3 domain and nuclear localization signals, 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SAMSN1 mRNA
CTD
PMID:27935865
NCBI chr16:75,655,682...75,706,154
Ensembl chr16:75,655,681...75,819,169
G
Sbk2
SH3-binding domain kinase family, member 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SBK2 mRNA
CTD
PMID:27935865
NCBI chr 7:4,959,133...4,967,405
Ensembl chr 7:4,943,511...4,967,405
G
Scg3
secretogranin III
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SCG3 mRNA
CTD
PMID:27935865
NCBI chr 9:75,550,648...75,591,733
Ensembl chr 9:75,550,471...75,591,338
G
Scgb2b12
secretoglobin, family 2B, member 12
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SCGB2B12 mRNA
CTD
PMID:27935865
NCBI chr 7:32,024,711...32,026,670
Ensembl chr 7:32,024,711...32,026,670
G
Scgb2b19
secretoglobin, family 2B, member 19
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SCGB2B19 mRNA
CTD
PMID:27935865
NCBI chr 7:32,977,791...32,979,766
Ensembl chr 7:32,977,795...32,979,763
G
Scgb2b20
secretoglobin, family 2B, member 20
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SCGB2B20 mRNA
CTD
PMID:27935865
NCBI chr 7:33,063,768...33,065,744
Ensembl chr 7:33,063,768...33,065,747
G
Scgb2b7
secretoglobin, family 2B, member 7
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SCGB2B7 mRNA
CTD
PMID:27935865
NCBI chr 7:31,403,204...31,405,179
Ensembl chr 7:31,403,204...31,405,182
G
Sell
selectin, lymphocyte
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SELL mRNA
CTD
PMID:27935865
NCBI chr 1:163,889,556...163,908,354
Ensembl chr 1:163,889,551...163,911,750
G
Selp
selectin, platelet
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SELP mRNA
CTD
PMID:27935865
NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
G
Serpinb3c
serine (or cysteine) peptidase inhibitor, clade B, member 3C
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SERPINB3C mRNA
CTD
PMID:27935865
NCBI chr 1:107,198,931...107,206,101
Ensembl chr 1:107,198,931...107,206,101
G
Sfrp1
secreted frizzled-related protein 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SFRP1 mRNA]
CTD
PMID:29891994
NCBI chr 8:23,901,401...23,939,648
Ensembl chr 8:23,901,518...23,939,648
G
Sh2d5
SH2 domain containing 5
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SH2D5 mRNA
CTD
PMID:27935865
NCBI chr 4:137,977,722...137,988,279
Ensembl chr 4:137,977,714...137,988,643
G
Shisa8
shisa family member 8
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SHISA8 mRNA
CTD
PMID:27935865
NCBI chr15:82,091,153...82,097,004
Ensembl chr15:82,090,369...82,097,016
G
Shox2
SHOX homeobox 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SHOX2 mRNA
CTD
PMID:27935865
NCBI chr 3:66,879,056...66,889,104
Ensembl chr 3:66,879,060...66,889,104
G
Slc12a8
solute carrier family 12 (potassium/chloride transporters), member 8
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC12A8 mRNA
CTD
PMID:27935865
NCBI chr16:33,337,440...33,484,508
Ensembl chr16:33,337,698...33,484,505
G
Slc1a3
solute carrier family 1 (glial high affinity glutamate transporter), member 3
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SLC1A3 mRNA]
CTD
PMID:29891994
NCBI chr15:8,663,608...8,742,648
Ensembl chr15:8,663,608...8,740,248
G
Slc1a5
solute carrier family 1 (neutral amino acid transporter), member 5
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SLC1A5 mRNA]
CTD
PMID:29891994
NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
G
Slc25a34
solute carrier family 25, member 34
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC25A34 mRNA
CTD
PMID:27935865
NCBI chr 4:141,346,130...141,351,202
Ensembl chr 4:141,346,135...141,351,132
G
Slc26a7
solute carrier family 26, member 7
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC26A7 mRNA
CTD
PMID:27935865
NCBI chr 4:14,502,430...14,621,946
Ensembl chr 4:14,502,430...14,621,805
G
Slc2a13
solute carrier family 2 (facilitated glucose transporter), member 13
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC2A13 mRNA
CTD
PMID:27935865
NCBI chr15:91,151,894...91,457,467
Ensembl chr15:91,151,899...91,457,464
G
Slc2a3
solute carrier family 2 (facilitated glucose transporter), member 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC2A3 mRNA
CTD
PMID:27935865
NCBI chr 6:122,704,783...122,779,149
Ensembl chr 6:122,704,768...122,778,599
G
Slc38a11
solute carrier family 38, member 11
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC38A11 mRNA
CTD
PMID:27935865
NCBI chr 2:65,144,007...65,194,606
Ensembl chr 2:65,146,774...65,194,378
G
Slc38a5
solute carrier family 38, member 5
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC38A5 mRNA
CTD
PMID:27935865
NCBI chr X:8,137,620...8,146,418
Ensembl chr X:8,137,372...8,146,418
G
Slc5a7
solute carrier family 5 (choline transporter), member 7
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLC5A7 mRNA
CTD
PMID:27935865
NCBI chr17:54,580,618...54,606,071
Ensembl chr17:54,580,618...54,606,062
G
Slc6a12
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SLC6A12 mRNA
CTD
PMID:27935865
NCBI chr 6:121,319,533...121,342,732
Ensembl chr 6:121,320,035...121,342,734
G
Sln
sarcolipin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SLN mRNA
CTD
PMID:27935865
NCBI chr 9:53,757,535...53,761,133
Ensembl chr 9:53,757,448...53,761,844
G
Snph
syntaphilin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SNPH mRNA
CTD
PMID:27935865
NCBI chr 2:151,432,469...151,474,527
Ensembl chr 2:151,432,469...151,474,513
G
Sorcs1
sortilin-related VPS10 domain containing receptor 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SORCS1 mRNA
CTD
PMID:27935865
NCBI chr19:50,131,733...50,668,030
Ensembl chr19:50,131,737...50,667,084
G
Sox10
SRY (sex determining region Y)-box 10
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SOX10 mRNA
CTD
PMID:27935865
NCBI chr15:79,039,113...79,048,690
Ensembl chr15:79,039,108...79,049,440
G
Sox9
SRY (sex determining region Y)-box 9
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SOX9 mRNA]
CTD
PMID:29891994
NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586
G
Spats2l
spermatogenesis associated, serine-rich 2-like
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of SPATS2L mRNA]
CTD
PMID:29891994
NCBI chr 1:57,813,261...57,987,557
Ensembl chr 1:57,813,321...57,987,553
G
Spon1
spondin 1, (f-spondin) extracellular matrix protein
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SPON1 mRNA
CTD
PMID:27935865
NCBI chr 7:113,365,235...113,642,610
Ensembl chr 7:113,365,235...113,642,605
G
Sprr1b
small proline-rich protein 1B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR1B mRNA
CTD
PMID:27935865
NCBI chr 3:92,344,115...92,346,124
Ensembl chr 3:92,344,116...92,346,096
G
Sprr2b
small proline-rich protein 2B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2B mRNA
CTD
PMID:27935865
NCBI chr 3:92,224,012...92,225,448
Ensembl chr 3:92,223,927...92,225,392
G
Sprr2d
small proline-rich protein 2D
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2D mRNA
CTD
PMID:27935865
NCBI chr 3:92,246,447...92,248,187
Ensembl chr 3:92,246,447...92,248,180
G
Sprr2e
small proline-rich protein 2E
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2E mRNA
CTD
PMID:27935865
NCBI chr 3:92,259,450...92,260,757
Ensembl chr 3:92,259,450...92,260,756
G
Sprr2f
small proline-rich protein 2F
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2F mRNA
CTD
PMID:27935865
NCBI chr 3:92,272,494...92,273,754
Ensembl chr 3:92,272,494...92,273,749
G
Sprr2g
small proline-rich protein 2G
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2G mRNA
CTD
PMID:27935865
NCBI chr 3:92,281,222...92,282,536
Ensembl chr 3:92,281,222...92,282,536
G
Sprr2h
small proline-rich protein 2H
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2H mRNA
CTD
PMID:27935865
NCBI chr 3:92,292,992...92,294,631
Ensembl chr 3:92,292,992...92,294,631
G
Sprr2i
small proline-rich protein 2I
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2I mRNA
CTD
PMID:27935865
NCBI chr 3:92,315,298...92,316,577
Ensembl chr 3:92,315,298...92,316,578
G
Sprr2j-ps
small proline-rich protein 2J, pseudogene
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2J-PS mRNA
CTD
PMID:27935865
NCBI chr 3:92,325,394...92,326,703
Ensembl chr 3:92,325,389...92,326,703
G
Sprr2k
small proline-rich protein 2K
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SPRR2K mRNA
CTD
PMID:27935865
NCBI chr 3:92,339,889...92,341,234
Ensembl chr 3:92,339,889...92,341,232
G
Srgn
serglycin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of SRGN mRNA
CTD
PMID:27935865
NCBI chr10:62,329,612...62,363,224
Ensembl chr10:62,329,612...62,363,230
G
Srpx
sushi-repeat-containing protein
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SRPX mRNA
CTD
PMID:27935865
NCBI chr X:9,904,216...9,983,879
Ensembl chr X:9,904,216...9,983,948
G
St6galnac2
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ST6GALNAC2 mRNA]
CTD
PMID:29891994
NCBI chr11:116,567,529...116,586,608
Ensembl chr11:116,566,129...116,585,694 Ensembl chr11:116,566,129...116,585,694
G
Stard10
StAR related lipid transfer domain containing 10
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of STARD10 mRNA]
CTD
PMID:29891994
NCBI chr 7:100,966,293...100,995,833
Ensembl chr 7:100,966,293...100,995,833
G
Stc2
stanniocalcin 2
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of STC2 mRNA]
CTD
PMID:29891994
NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074
G
Stfa2
stefin A2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of STFA2 mRNA
CTD
PMID:27935865
NCBI chr16:36,224,308...36,228,725
Ensembl chr16:36,224,354...36,228,819
G
Stfa2l1
stefin A2 like 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of STFA2L1 mRNA
CTD
PMID:27935865
NCBI chr16:35,977,181...35,982,318
Ensembl chr16:35,977,181...35,982,323
G
Stfa3
stefin A3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of STFA3 mRNA
CTD
PMID:27935865
NCBI chr16:36,270,899...36,275,754
Ensembl chr16:36,270,899...36,275,754
G
Stxbp5l
syntaxin binding protein 5-like
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of STXBP5L mRNA
CTD
PMID:27935865
NCBI chr16:36,927,437...37,205,377
Ensembl chr16:36,935,304...37,205,324
G
Susd5
sushi domain containing 5
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SUSD5 mRNA
CTD
PMID:27935865
NCBI chr 9:113,886,422...113,927,801
Ensembl chr 9:113,886,208...113,927,796
G
Svopl
SV2 related protein homolog (rat)-like
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of SVOPL mRNA
CTD
PMID:27935865
NCBI chr 6:37,960,674...38,023,944
Ensembl chr 6:37,960,674...38,023,931
G
Tagln
transgelin
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TAGLN mRNA; XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TAGLN mRNA]
CTD
PMID:27935865 PMID:29891994
NCBI chr 9:45,840,926...45,847,356
Ensembl chr 9:45,840,917...45,847,356
G
Tarm1
T cell-interacting, activating receptor on myeloid cells 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TARM1 mRNA
CTD
PMID:27935865
NCBI chr 7:3,535,015...3,551,159
Ensembl chr 7:3,535,016...3,551,140
G
Tbc1d16
TBC1 domain family, member 16
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TBC1D16 mRNA]
CTD
PMID:29891994
NCBI chr11:119,033,869...119,119,354
Ensembl chr11:119,033,871...119,119,325
G
Tbx15
T-box 15
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TBX15 mRNA
CTD
PMID:27935865
NCBI chr 3:99,147,671...99,261,576
Ensembl chr 3:99,147,697...99,261,575
G
Tbxa2r
thromboxane A2 receptor
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TBXA2R mRNA
CTD
PMID:27935865
NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
G
Tdo2
tryptophan 2,3-dioxygenase
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TDO2 mRNA
CTD
PMID:27935865
NCBI chr 3:81,865,719...81,883,035
Ensembl chr 3:81,864,397...81,883,509
G
Tff2
trefoil factor 2 (spasmolytic protein 1)
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TFF2 mRNA
CTD
PMID:27935865
NCBI chr17:31,360,036...31,363,256
Ensembl chr17:31,360,023...31,363,256
G
Tgm2
transglutaminase 2, C polypeptide
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TGM2 mRNA]
CTD
PMID:29891994
NCBI chr 2:157,958,325...157,988,312
Ensembl chr 2:157,958,322...157,988,356
G
Thrsp
thyroid hormone responsive
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of THRSP mRNA
CTD
PMID:27935865
NCBI chr 7:97,062,140...97,066,757
Ensembl chr 7:97,062,145...97,066,937
G
Timp1
tissue inhibitor of metalloproteinase 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TIMP1 mRNA
CTD
PMID:27935865
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Tlr12
toll-like receptor 12
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TLR12 mRNA
CTD
PMID:27935865
NCBI chr 4:128,509,239...128,512,412
Ensembl chr 4:128,509,236...128,512,412
G
Tlr13
toll-like receptor 13
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TLR13 mRNA
CTD
PMID:27935865
NCBI chr X:105,186,881...105,204,099
Ensembl chr X:105,186,810...105,204,099
G
Tmem132c
transmembrane protein 132C
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM132C mRNA
CTD
PMID:27935865
NCBI chr 5:127,318,890...127,642,854
Ensembl chr 5:127,318,872...127,642,857
G
Tmem182
transmembrane protein 182
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM182 mRNA
CTD
PMID:27935865
NCBI chr 1:40,844,738...40,896,047
Ensembl chr 1:40,844,761...40,896,047
G
Tmem252
transmembrane protein 252
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TMEM252 mRNA
CTD
PMID:27935865
NCBI chr19:24,651,372...24,657,025
Ensembl chr19:24,651,372...24,659,597
G
Tmem255a
transmembrane protein 255A
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TMEM255A mRNA
CTD
PMID:27935865
NCBI chr X:37,285,450...37,341,373
Ensembl chr X:37,285,450...37,341,316
G
Tmem30b
transmembrane protein 30B
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TMEM30B mRNA]
CTD
PMID:29891994
NCBI chr12:73,589,888...73,593,169
Ensembl chr12:73,590,176...73,593,166
G
Tnc
tenascin C
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNC mRNA]
CTD
PMID:29891994
NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252
G
Tnfrsf14
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNFRSF14 mRNA]
CTD
PMID:29891994
NCBI chr 4:155,002,944...155,013,077
Ensembl chr 4:155,006,390...155,013,020
G
Tnfrsf26
tumor necrosis factor receptor superfamily, member 26
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TNFRSF26 mRNA
CTD
PMID:27935865
NCBI chr 7:143,161,422...143,181,690
Ensembl chr 7:143,161,396...143,182,459
G
Tnfsf14
tumor necrosis factor (ligand) superfamily, member 14
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TNFSF14 mRNA
CTD
PMID:27935865
NCBI chr17:57,496,437...57,501,182
Ensembl chr17:57,496,492...57,501,177
G
Tnfsf9
tumor necrosis factor (ligand) superfamily, member 9
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TNFSF9 mRNA
CTD
PMID:27935865
NCBI chr17:57,412,113...57,414,757
Ensembl chr17:57,412,325...57,414,757
G
Tnni2
troponin I, skeletal, fast 2
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TNNI2 mRNA]
CTD
PMID:29891994
NCBI chr 7:141,995,553...141,998,147
Ensembl chr 7:141,995,545...141,998,147
G
Tnnt1
troponin T1, skeletal, slow
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TNNT1 mRNA
CTD
PMID:27935865
NCBI chr 7:4,507,568...4,518,974
Ensembl chr 7:4,507,569...4,519,381
G
Tpd52l1
tumor protein D52-like 1
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TPD52L1 mRNA]
CTD
PMID:29891994
NCBI chr10:31,208,369...31,321,989
Ensembl chr10:31,208,372...31,321,954
G
Trarg1
trafficking regulator of GLUT4 (SLC2A4) 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TRARG1 mRNA
CTD
PMID:27935865
NCBI chr11:76,570,699...76,589,490
Ensembl chr11:76,570,634...76,589,490
G
Trem1
triggering receptor expressed on myeloid cells 1
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TREM1 mRNA
CTD
PMID:27935865
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
G
Trem3
triggering receptor expressed on myeloid cells 3
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TREM3 mRNA
CTD
PMID:27935865
NCBI chr17:48,554,707...48,565,876
Ensembl chr17:48,554,805...48,565,869
G
Tril
TLR4 interactor with leucine-rich repeats
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TRIL mRNA
CTD
PMID:27935865
NCBI chr 6:53,792,453...53,797,810
Ensembl chr 6:53,792,453...53,797,815
G
Trim30b
tripartite motif-containing 30B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TRIM30B mRNA
CTD
PMID:27935865
NCBI chr 7:104,004,605...104,007,853
Ensembl chr 7:104,004,589...104,019,091
G
Tst
thiosulfate sulfurtransferase, mitochondrial
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of TST mRNA]
CTD
PMID:29891994
NCBI chr15:78,283,756...78,290,065
Ensembl chr15:78,283,756...78,290,107
G
Tubb3
tubulin, beta 3 class III
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of TUBB3 mRNA
CTD
PMID:27935865
NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754
G
Twist2
twist basic helix-loop-helix transcription factor 2
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TWIST2 mRNA
CTD
PMID:27935865
NCBI chr 1:91,729,183...91,775,756
Ensembl chr 1:91,729,183...91,775,750
G
Txlnb
taxilin beta
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of TXLNB mRNA
CTD
PMID:27935865
NCBI chr10:17,671,967...17,721,411
Ensembl chr10:17,671,974...17,721,413
G
U90926
cDNA sequence U90926
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of U90926 mRNA
CTD
PMID:27935865
NCBI chr 5:92,357,754...92,363,211
Ensembl chr 5:92,357,752...92,363,267
G
Upk3a
uroplakin 3A
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of UPK3A mRNA
CTD
PMID:27935865
NCBI chr15:84,901,342...84,906,761
Ensembl chr15:84,901,342...84,906,748
G
Wfdc17
WAP four-disulfide core domain 17
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of WFDC17 mRNA
CTD
PMID:27935865
NCBI chr11:83,594,882...83,597,095
Ensembl chr11:83,594,817...83,597,094
G
Wfdc21
WAP four-disulfide core domain 21
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in increased expression of WFDC21 mRNA
CTD
PMID:27935865
NCBI chr11:83,637,766...83,643,472
Ensembl chr11:83,637,766...83,643,468
G
Wnt2b
wingless-type MMTV integration site family, member 2B
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of WNT2B mRNA
CTD
PMID:27935865
NCBI chr 3:104,852,121...104,869,025
Ensembl chr 3:104,852,588...104,869,237
G
Zfp366
zinc finger protein 366
multiple interactions
EXP
[N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ZFP366 mRNA
CTD
PMID:27935865
NCBI chr13:99,321,331...99,383,540
Ensembl chr13:99,321,331...99,387,164
G
Zfp524
zinc finger protein 524
multiple interactions
EXP
XL147 inhibits the reaction [N-nitroso-tris-chloroethylurea results in increased expression of ZNF524 mRNA]
CTD
PMID:29891994
NCBI chr 7:5,018,142...5,021,487
Ensembl chr 7:5,017,414...5,021,487
G
Aldh5a1
aldhehyde dehydrogenase family 5, subfamily A1
increases response to substance
EXP
ALDH5A1 gene mutant form results in increased susceptibility to XL765
CTD
PMID:29031482
NCBI chr13:25,091,562...25,121,740
Ensembl chr13:25,091,562...25,121,644
G
Mtor
mechanistic target of rapamycin kinase
decreases activity
EXP
XL765 results in decreased activity of MTOR protein
CTD
PMID:29031482
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all